15 CHEMOTHERAPY OF CANCER AND IMMUNOSUPPRESSION

15A CHEMOTHERAPY OF CANCER

15AA Alkylating agents
15-AA0-001 Busulphan 2mg Tablet

15-AA0-002 Carmustine 100mg I.V. Injection EDL1

15-AA0-003 Chlorambucil 2mg Tablet ( see10AC) EDL2
15-AA0-005 Cyclophosphamide 50mg Tablet EDL2
15-AA0-006 Cyclophosphamide 100mg Injection

15-AA0-007 Cyclophosphamide 200mg Injection EDL2

15-AA0-008 Cyclophosphamide 500mg Injection EDL1
15-AA0-009 Dacarbazine 100mg either I.V. Infusion or in certain
tumer by intra-arterial perfusion Vial &in this case
Note : the drug after reconstitution and during
infusion should be kept out of light

15-AA0-010 Dacarbazine 200mg powder for reconstituition vial for

inj (I.V. Infusion or I.V. infusion and Intra-arterial
perfusion) EDL1

15-AA0-011 Ifosfamide 500mg Injection EDL2

15-AA0-012 Ifosfamide 1g I.V. Injection

15-AA0-013 Ifosfamide 2g pawder for reconstitution for I.V

injection
EDL1

15-AA0-014 Lomustine 10mg Capsule

15-AA0-015 Lomustine 40mg Capsule EDL2

15-AA0-018 Melphalan 2mg Tablet EDL1
15-AA0-020 Mesna 100mg/ml, (4ml) Injection EDL1
15-AA0-021 Mesna 100mg/ml (2ml) Injection

15-AA0-023 Cyclophosphamide 1g Injection

15-AA0-024 Melphalan 50 mg (as HCl) powder for reconstitution

vial ( with solvent-diluent )
EDL1

15-AA0-025 Busulphan 60mg I.V Injection(10 ml vial) EDL1

15-AA0-026 Busulphan 25mg Tablet

15-AA0-027 Temozolomide 20mg capsule EDL2

15-AA0-028 Temozolomide 100mg capsule EDL1
15-AA0-029 Mesna 400mg tablet Tab Mesna inj ‫ال يعتبر بديل‬
‫عن‬

15-AA0-030 Bendamustine hydrochloride 100mg vial powder for

reconstitution
EDL1

15AB Antimetabolites
15-AB0-005 Cladribine (2 - CDA) 2mg /ml solution (5ml)
Ampoule

15-AB0-021 Cladribine (2-CDA) 2mg /ml Solution (10mg/5ml)

Vial

15-AB0-020 Cladribine (2-CDA) 10mg / Vial, 5ml Or 10ml

‫( يحصر استخدامه لعالج اللوكيميا الشعيرية‬Hairy cell
Leukemia) EDL1

15-AB0-022 cytarabine (for S.C, I.V. )1g/10ml or 1g/20ml vial

(not all cytarabin preparation can be given by
intrathecal inj .- consult Product literature )
EDL1

15-AB0-001 cytarabine (for S.C, I.V. , intrathecal ) 20mg/ml, 5 ml

vial
(not all cytarabin preparation can be given by
EDL1
intrathecal inj .- consult Product literature )

15-AB0-002 Cytarabine ocfosfate 50mg Tablet

15-AB0-003 Cytarabine ocfosfate 100mg Capsule

15-AB0-004 Cytarabine ocfosfate 100mg Tablet

15-AB0-007 5-Flurouracil 25mg/ml (10,20,100)ml vial for I.V

inj. Or infusion oR intra-arterial infusion
EDL2

15-AB0-028 5-Flurouracil 50mg/ml (10,20,50,100)ml vial for

I.V inj. Or infusion oR intra-arterial infusion
EDL1
15-AB0-029 Fluorouracil 5% CREAM EDL1
15-AB0-008 Gemcitabine as Hcl 1g powder for reconstitution /
vial or concentcate for solution for infusion 10 mg /
EDL1
ml (1g )

15-AB0-009 6- mercaptopurine 50mg Tablet EDL1

15-AB0-010 Methotrexate 2.5mg Tablet EDL1
15-AB0-011 Methotrexate 5mg/ml vail OR amp ( 1ml or 2ml ) for (
I.V, I.M , intrathecal) with or without other route of
administration according to scientific refrences EDL1

15-AB0-016 Methotrexate 50mg vial OR amp with lyophylized

powder OR sol . With 10 mg / ml (5ml ) OR 25 mg
/ml(2ml) for (I.V , I.M , intrathecal ) with or without
other route of administration according to scientific EDL2
refrences

15-AB0-017 Thioguanine 40mg Tablet

15-AB0-019 Fludarabine phosphate 50mg vial, powder for

reconstitution, for I.V. inj. or infusion.
EDL1

15-AB0-027 Fludarabine phosphate 10mg Tablet

15-AB0-030 Cytarabine encapsulated in liposome injection 50mg

I.T vial

15-AB0-031 Decitabine I.V injection 50mg vial EDL1

15-AB0-033 Methotrexate 1000 mg vial Or amp. With
concentration of 100 mg/ ml ( 10 ml ) OR 25 mg/ ml
( 40 ml ) for I.V infusion . EDL1

15-AB0-034 Pemetrexed (as Pemetrexed di - sodium) in 500mg

vial Folate analogue
EDL1
15-AB0-035 Pemetrexed (as Pemetrexed di - sodium) injection
100mg vial
EDL3

15-AB0-036 Methotrexate 500mg vial or amp.with concentration

of 25 mg/ ml ( 20ml ) for I.V infusin
EDL2

15-AB0-037 Clofarabine 1 mg / ml (20ml vial) I.V infusion

EDL3

15-AB0-038 Methotrexate 50MG /ML(7.5 , 10 ,15 ,20 MG) PFS

15-AB0-039 Methortexate 5000mg vial OR falcon wnith

concetration of 100 mg /ml (50ml ) , 25mg/ml
( 200ml) for I.V infusion .

15-AB0-040 Methotrexate disodium 25 mg / 0.5 ml solutionfor

injection pre-filled syringe with embedded sc needl

15AC Antibiotics
15-AC0-002 Bleomycin as sulphate 15000 units per vial dry
powder for reconstitution
EDL1

15-AC0-003 Dactinomycin 500mcg (Actinomycin D) I.V

Injection
EDL1

15-AC0-004 Daunorubicin 20mg I.V. Injection (as Hcl) powder for

reconstitution vial
EDL1

15-AC0-005 Doxorubicin Hcl 10mg I.V. inj powder / Vial OR

10mg I.V. inj (5ml solution )Vial OR 10mg rapid
dissolution I.V. inj powder/ Vial EDL2

15-AC0-008 Doxorubicin Hcl 50 mg I.V. inj , powder for

reconstitution vial OR Doxorubicin Hcl 2mg/ml, 25
ml vial. Note:- I.A = Intra – arterial Ives = Intra- EDL1
Vesical
15-AC0-018 Doxorubicin Hcl (pegylated liposomal )conc.for i.v
infusion 2mg/ml(10ml vial )i.e inj pegylated
Doxorubicin Hcl 2mg /ml incapsulated in liposomes EDL1

15-AC0-012 Mitomycin 2mg I.V. bladder instillation Injection

15-AC0-013 Mitomycin 10mg , powder for reconstitution vial for

I.V. and bladder instillation Injection
EDL2

15-AC0-014 Mitoxantrone as Hcl , concentrate for I.V. infusion,

2mg/ml, 10 ml vial
EDL1

15-AC0-015 Idarubicin Hcl 5mg Vial

15-AC0-019 Epirubicin Hcl 2mg/ml, 25 ml vial or Epirubicin Hcl

50 mg (powder for reconstitution ) vial.
EDL1

00-000-00 Fulvestrant 250 mg / 5 ml for im only

15AD Vinca alkaloids and etoposide

15-AD0-002 Etoposide 50mg Capsule EDL2
15-AD0-003 Etoposide 100mg Capsule EDL2
15-AD0-004 Etoposide concentrate for I.V. infusion 20mg/ml, 5
ml vial or ampoul.
EDL1

15-AD0-006 Vinblastine sulphate 1 mg/ml, 10 ml vial or ampoul.

EDL1

15-AD0-007 Vincristine sulphate Injection 1mg/ml , 1 ml inj. for

I.V. adminstration only not for intrathecal
EDL1
adminstration.

15-AD0-008 Vincristine sulphate 5mg I.V. Injection(I.V. only)

15-AD0-011 Vinorelbine as tartrate , concentrate for I.V. infusion

10 mg/ml, 5 ml vial.
EDL1

15-AD0-012 as tartrate I.V

Vinorelbine as ditartrate or
inj 10mg /1ml Vial
15-AD0-014 Vinorelbine as tartrate 20 mg capsule EDL2
15-AD0-015 Vinorelbine as tartrate 30 mg capsule EDL1
15AE Enzymes
15-AE0-001

EDL2

L-asparginase 10000 IU IM, IV source either

15-AE0-002 Pegylated L.asparginase 750 I.U / ml (5ml vial)
(3750I.U/ vial)
EDL2

Recombinant asparginase (E-coli type ) 10.000 unit

vial powder for concentrate for
solution for infusion EDL1

15-AE0-003
15AF Miscellaneous agents
15-AF0-002 Cisplatin inj 10mg I.V. infusion or Cisplatin inj
10mg/20ml Vial I.V. infusion, intraperitoneal
EDL2
instillation

15-AF0-003 Cisplatin inj 50mg I.V. infusion or 50mg/50ml I.V.

infusion Vial
EDL1

15-AF0-034 Cisplatin inj 10mg/10ml I.V. infusion -Vial

15-AF0-004 Oxaliplatin 50mg/ Vial powder for solution I.V.

Infusion (limited use )

15-AF0-005 Oxaliplatin 100mg/vial powder for reconstitution

I.V.Infusion or concentrate for I.V. infusion 5mg/ml ,
20 ml vial. EDL1

15-AF0-006 Carboplatin 15mg I.V. Infusion

15-AF0-007 Carboplatin 10mg/ml inj (15ml) Vial i-e

150mg/15ml
EDL3

15-AF0-008 Carboplatin 10mg/ml (45ml) Vial i-e 450mg/45ml

EDL1

15-AF0-010 Hydroxyurea 500mg Capsule EDL1

15-AF0-011 Octreotide 0.05mg/ml Injection EDL1
15-AF0-012 Octreotide 0.1mg/ml Injection

15-AF0-030 Octreotide as acetate 20mg microspheres powder for

suspension vial
EDL1

Octreotide 0.5mg/ 1ml ( I.V. Infusion ,I.M ) or ( SC,

IV Infusion ) Ampoule
15-AF0-046
15-AF0-059 Octreotide 30mg vial (in form of microspheres) : :
(microsphere powder for aqueous suspension)
octreotide (as acetate) 30 mg vial supplied with 2.5ml
EDL1
diluent filled syringe

15-AF0-069 lanreotide acetate 90 mg sol. for Inj (PFS) Autogel

EDL1

15-AF0-070 lanreotide acetate 120 mg sol. for Inj (PFS) Autogel

EDL1

Lanerotide as acetate 30 mg I.M. injection vial or pfs

15-AF0-052
15-AF0-014 Procarbazine 50mg Capsule EDL2
15-AF0-015 Promod powder (Special diet for cancering patient)

15-AF0-018 Methyl Prednisolon (As sodium Succinate) 250 mg

I.M, slow I.V.inj., I.V infusion
EDL1

15-AF0-019 Methyl prednisolon (as sod. Succinate) 125 mg

I.V,I.M injection ‫ تكون طريقة الزرق‬:‫ مالحظة‬I.V, I.M ‫لكل‬
1 ‫التراكيز المقرة للمادة أنفًا عدا تركيز‬g ‫ فيكون‬I.V. 686( ‫فقط‬
15-AF0-020 Methyl prednisolon (as sod. succinate )500 mg
I.V,I.M inj with water for injection with Benzyl
alcohol 9mg/ml (limited use)‫لكل التراكيز المقرة للمادة انفا‬
‫ عدا تركيز‬I.V,I.M ‫تكون طريقة الزرق‬ EDL3
1 g ‫فيكون‬I.V ‫فقط‬

15-AF0-041 Methylprednisolone as sodium succinate 20mg

I.V,deep I.M. inj. Vial

15-AF0-042 Methylprednisolone as sodium succinate 40mg

I.V,deep I.M. inj. Vial

15-AF0-031 Tretinoin (ALL- trans Retinoic acid) 10mg cap

EDL1

15-AF0-032 Alglucerase I.V. infusion injection

15-AF0-037 Capecitabine 150mg tablet

15-AF0-038 Capecitabine 500mg tablet EDL1

15-AF0-043 Bevacizumab 100 mg ;concentrate for intravenous
infusion 25mg/ml, 4 ml vial
EDL1

15-AF0-044 Bevacizumab 400 mg ;concentrate for intravenous

infusion 25mg/ml, 16 ml vial
EDL1

00-000-00 MVASI :bevacizumab 400mg/16ml

Biosimilar
00-000-00 MVASI :bevacizumab 100mg/16ml
Biosimilar
15-AF0-045 Quadrivalent Human papillomavirus (HPV) of types
6(20 mcg), 11(40 mcg),16(40 mcg),18(20 mcg))
Recombinant vaccine I.M. administration – 0.5 ml
vial

15-AF0-047 Cetuximab 5mg/ml 20 ml infusion

15-AF0-049 Oxaliplatin injection 5mg/ml I.V. Infusion,solution

(10ml vial)

15-AF0-051 Bortezomib( as mannitol boronic ester )inj.3.5 mg i.v,

s.c vial
EDL1
15-AF0-053 Topotecan (as Hcl) I.V Infusion powder for
reconstitution 1 mg/ vial.
EDL2

15-AF0-054 Topotecan (as Hcl) I.V Infusion powder for

reconstitution 4 mg/ vial.
EDL2

15-AF0-055 Methyl prednisolone (as sod. Succinate) 125 mg/2 ml

ACT-O vial I.V,I.M use + diluent in the same vial

15-AF0-056 Somatostatin (synthetic) as acetate I.V. inj 250 mcg –

vial

15-AF0-057 Oxaliplatin conc. Solution for infusion i.v use 5mg/ml

(40 ml vial) dilute befor use

15-AF0-061 Arsenic trioxide( Concentrate for intravenous

infusion)1 mg/mL, net price 10-mL amp
EDL1

15-AF0-062 Brentuximab Vedotin 50mg vial EDL1

15-AF0-063 Ramucirumab 100 mg/ vial for I.V use

15-AF0-064 Ramucirumab 500 mg/ vial for I.V use

15-AF0-036 Trastuzumab( HER2)( Recombinant ) 440mg/Vial

EDL1

00-000-00 Recombinant HER2 (Trastuzumab) inj 420mg/ vial.

15-AF0-048 Recombinant( HER2)( Trastuzumat ) i.v infusion

150mg/Vial
EDL3

00-000-00 Trastuzumab 600mg / 5 ml solution for injection vial

S.C
EDL1

15-AF0-071 Pertuzumab 420 mg IV vial

15-AF0-065 Herzuma : Recombinant HER2 (Trastuzumab) inj

420mg/ vial.
Biosimilar

15-AF0-066 Herzuma : Recombinant HER2 (Trastuzumab) inj

150mg/ vial.
Biosimilar

15-AF0-067 Trazimera : Recombinant HER2 (Trastuzumab) inj

420mg/ vial
Biosimilar
15-AF0-068 Trazimera : Recombinant HER2 (Trastuzumab) inj
150mg/ vial
Biosimilar

15AG Hormones and antagonists

15-AG0-002 Flutamide 250mg Tablet (Scored tab is preferable)
EDL3

15-AG0-003 Flutamide 250mg Capsule

15-AG0-004 Flutamide 125mg Capsule

15-AG0-008 Letrozol 2.5mg Tablet (For endometriosis &

advanced breast cancer only)
EDL1

15-AG0-009 Medroxyprogesterone acetate 150mg/ml deep I.M .

Inj (3.3ml vial) or 500mg deep I.M. inj Vial

15-AG0-010 Medroxyprogesterone acetate 100mg Tablet

15-AG0-011 Medroxyprogesterone acetate 250mg Tablet

15-AG0-012 Tamoxifen as citrate 10mg Tablet

15-AG0-013 Tamoxifen as citrate 20mg Tablet EDL1

15-AG0-014 Anastrozole 1mg Tablet

EDL1

15-AG0-015 Bicalutamide 50mg tablet / Not use in cases

of Localize prostatic disease
EDL1

15-AG0-016 Bicalutamide 150mg tablet / Not use in cases

of Localize prostatic disease
EDL2

15-AG0-017 Cyproterone acetate 100mg Tablet

15-AG0-018 Goserelin as acetate implant 10.8mg in safe system

syringe applicator

15-AG0-019 Degarelix as acetate 80 mg s.c inj. Vial

15-AG0-020 Degarelix as acetate 120 mg s.c inj. Vial

15-AG0-021 Abiraterone acetate 250 mg tablet EDL1

15-AG0-022 Exemestane 25mg film coated tablet EDL2
15-AG0-023 Fluvestrant 250 mg /5 ml inj for im only

Enzalutamide 40mg cap capsule

15-AG0-024 EDL1

00-000-00 Megestrol acetate

15B DRUGS THAT ALTER

IMMUNE RESPONSES
(Drugs affecting the
immune responses)
15-B00-001 Azathioprine 50mg Tablet(also use in 2E) EDL1
15-B00-002 Azathioprine 50mg Injection

Cyclosporine (Microemulsion) 25mg Capsule

15-B00-006

Cyclosporine (Microemulsion) 100mg Capsule

15-B00-007 EDL2

Cyclosporine (Microemulsion)100mg/ml oral

15-B00-008
Solution
EDL1

Cyclosporine concentrate for I.V infusion, 50mg/ml

15-B00-009
inj (1ml) Ampoule
EDL3

Cyclosporine 250mg/5ml inj (5ml) Ampoule

15-B00-010

Cyclosporine (Microemulsion) 50mg Capsule

15-B00-054

Anti-Thymocytic-Globulin (ATG,Rabbit type) for

I.V. infusion powder for reconstitution; 25 mg vial
OR ampoule)‫يحدد احتياجه من قبل مراكز زرع الكلى ومراكز‬
15-B00-073 EDL1
‫زرع النخاع‬

Anti-Thymocytic-Globulin 100mg/5ml (ATG) Vial

15-B00-003
(Rabbit type)
EDL1

Antithymocyte globulin equine 250 mg in 5 ml

ampoule ‫لعالج فشل نخاع العظم المكتسب‬
15-B00-088 EDL1
 Mycophenolate mofetil 250mg Capsule

‫بشكل منفصل واعتماد البروتوكول العالجي‬

15-B00-022 1033 ‫( مرفق جلسة‬mycophenolic acid) ‫اعتماد مادة‬ EDL3

Mycophenolate mofetil 500mg Tablet

‫بشكل منفصل واعتماد البروتوكول‬

15-B00-023 1033 ‫( العالجي مرفق جلسة‬mycophenolic acid) ‫اعتماد مادة‬ EDL1

Mycophenolic acid as sod.Salt i.e Mycophenolic acid

as mycophenolate sod.180mg Tablet
15-B00-052 EDL3

Mycophenolic acid as sod.Salt i.e Mycophenolic acid

as mycophenolate sod.360mg Tablet
15-B00-053 EDL1

Interferon Beta 1a (Recombimant) 12millon IU

15-B00-037
(44mcg) pfs
EDL1

Interferon alfa 2b ( Recombinant )25 MIU (5 dose x 5

MIU) , 2.5ml vial (HSAfree solution)
15-B00-038

Interferon alfa 2b (Recombinant )18 MIU (6 dose x 3

MIU) , 3ml vial (HSAfree solution)
15-B00-039

Interferon alfa-2a (Recombinant) 9 million units

prefilled syring (HSA free solution) Injection
15-B00-012 EDL1

Interferon alfa-2a (Recombinant) 3 million units

prefilled syring (HSA free solution) S.C Injection
15-B00-013
 Interferon alfa-2a (Recombinant) 6 million units
prefilled syring (HSA free solution)S.C Injection
15-B00-014

Interferon alfa 2b (Recombinant) 3 MIU /0.5ml S.C.

I.M, I.V. inj Vial (HSA free solution)
15-B00-015

Interferon alfa 2b (Recombinant) 5 MIU /0.5ml S.C.

I.M., I.V. inj Vial (HSA free solution)
15-B00-016

Interferon alfa 2b (Recombinant) 10 MIU / 1ml S.C,

I.M, I.V vial (HSA free solution) Injection
15-B00-017

Interferon alfa 2b (Recombinant) inj. Pen; 15 million

units/ml,1.5 ml cartridge for S.C or I.V. use ( each 1.5
ml multidose cartridge delivers 12 doses of 0.1 ml).
15-B00-018 EDL3

Interferon alfa 2b (Recombinant) 30 MIU (6 dose x 5

MIU) S.C Multi dose self pens (HSA free solution)
15-B00-019
Injection

Interferon Beta 1a 30mcg (6 million I.U) vial (I.M)

‫ يعطى للنوبات الحادة من مرض تصلب االعصاب المنتشرة‬single
15-B00-027 demyelinating event with active inflammatory procces EDL1

Interferon Beta 1a 30 mcg (6 million)IU / 0.5 ml pre-

filled syring solution for I.M. inj.
15-B00-083 EDL3

Interferon Beta 1a 30mcg (6 million I.U) /0.5 pre-

15-B00-093
filled pen solution for I.M inj

Interferon Beta 1a (Recombimant) 6millon IU

(22mcg) ml S.C.Injection ‫يعطى لمرض تصلب االعصاب‬
15-B00-020 ‫ المنتشرة للنوبات المتكررة الهادئة والمنتكسة‬remitting relapsing
 Recombinant Interferon Beta 1b 0.3mg(9.6 million
IU) S.C Inj. Vial. (Better to be free from Human
blood additives) ‫يعطى للنوبات الحادة من مرض تصلب‬

15-B00-051 ‫ االعصاب المنتشرة‬single demyelinating event with active EDL1

inflammatory .

Peginterferon alfa 2a (Recombinant) 135mcg/0.5ml

solution (Human serum albumin free) prefilled syring
15-B00-040

Peginterferon alfa 2b (Recombinant) 50mcg /0.5ml

when reconstituted-singl dose vial (without blood
addatives) s.c injection , note : ‫العدة التى‬
15-B00-042 EDL1
‫ تحتوى على الدوائين‬kit ‫تؤكد الهيئة على توفير‬

Peginterferon alfa 2b (Recombinant) 80mcg /0.5ml

when reconstituted-singl dose vial (without blood
15-B00-043 addatives) s.c injection

Peginterferon alfa 2b (Recombinant) 100mcg /0.5ml

when reconstituted-singl dose vial (without blood
15-B00-044 addatives) s.c injection EDL3

Peginterferon alfa 2b (Recombinant) 120mcg /0.5ml

when reconstituted-singl dose vial (without blood
15-B00-045 addatives) s.c injection EDL3

Peginterferon alfa 2b (Recombinant) 150mcg /0.5ml

when reconstituted-singl dose vial (without blood
15-B00-046 addatives) s.c injection

Peginterferon alfa 2a (Recombinant) 135mcg/1ml

solution (Human serum albumin free) (1ml) Vial
15-B00-032 EDL3
 Peginterferon alfa 2a inj (Recombinant) 180mcg/1ml
solution 1ml-vial (Human serum albumin free) (1ml)
Vial OR Peginterferon alfa 2a (Recombinant)
15-B00-033 EDL1
180mcg/0.5ml prefilled syring

Sirolimus 1mg Tablet

15-B00-047 EDL1

15-B00-048 Sirolimus 2mg Tablet EDL2

15-B00-049 Sirolimus 1mg/1ml oral solution

15-B00-059 Everolimus 1mg tablet

15-B00-097 Everolimus 5 mg Tab EDL2

15-B00-082 Everolimus 10 mg tablet EDL1
15-B00-065 Tacrolimus 0.5 mg Capsule EDL3
15-B00-024 Tacrolimus 1mg Capsule EDL1
15-B00-025 Tacrolimus 5mg Capsule

Tacrolimus concentrate 5mg/ml for I.V.infusion

(1ml) Ampoule (To be diluted before use)
15-B00-026

Tacrolimus prolonged release 0.5 mg hard gelatin cap.

15-B00-084

Tacrolimus prolonged release 1 mg hard gelatin cap.

15-B00-085

Tacrolimus prolonged release 3 mg hard gelatin cap.

15-B00-086 EDL2

Tacrolimus prolonged release 5 mg hard gelatin cap.

15-B00-087

Tacrolimus as monohydrate 0.03% ointment

15-B00-091 EDL3

Tacrolimus as monohydrate 0.1% ointment

15-B00-092 EDL2
 Peginterferon alfa 2b (Recombinant) 50mcg /0.5ml
when reconstituted-PF-Pen s.c injection
15-B00-060

Peginterferon alfa 2b (Recombinant) 80mcg /0.5ml

when reconstituted-PF-Pen s.c injection
15-B00-061

Peginterferon alfa 2b (Recombinant)100mcg /0.5ml

when reconstituted-PF-Pen s.c injection
15-B00-062

Peginterferon alfa 2b (Recombinant) 120mcg /0.5ml

when reconstituted-PF-Pen s.c injection
15-B00-063

Peginterferon alfa 2b (Recombinant) 150mcg /0.5ml

when reconstituted-PF-Pen s.c injection
15-B00-064

15-B00-076 Lenalidomide 10mg tablet EDL1

15-B00-077 Lenalidomide 10mg capsule

15-B00-078 Lenalidomide 25mg tablet EDL1

15-B00-079 Lenalidomide25mg capsule

15-B00-071 Thalidomide 50 mg cap. . EDL1

15-B00-072 Thalidomide 50 mg tab.

Natalizumab concentrate for I.V. infusion 20mg/ml,

15-B00-081
15 ml vial
EDL1

Pembrolizumab I.V inj .50 mg/vial

15-B00-098 EDL1

Pembrolizumab I.V inj .100 mg/vial

15-B00-104 EDL1

15-B00-100 Truxima: Rituximab 100 mg , 500 mg vial Biosimilar

15-B00-004 Basiliximab 20mg /Vial EDL1
Daclizumab (interleukin-2blocker)concentrate for
solution for infusion 5mg/ml 5ml vial for I.V use
15-B00-034 after dilution
 Rituximab(Recombinant) concentrate for I.V infusion
15-B00-035
10 mg/ml ;10ml vial
EDL3

Rituximab concentrate for I.V infusion 10mg/ml; 50

ml vial
15-B00-036 EDL1

Rixathon: Rituximab concentrate for infusion 100

15-B00-101
mg ,500mg vial, biosimalr
Biosimilar

Gefetinib 250 mg tab

15-B00-099 EDL2

15-B00-102 Ibrutinib 140 mg tab EDL1

15-B00-103 Afatinib 20mgtab

15-B00-104 Afatinib 30mgtab

15-B00-105 Afatinib 40mg, tab

15-B00-106 Afatinib 50mg tab

15-B00-107 Nintedanib 100mg soft cap

15-B00-108 Nintedanib 150mg soft cap

Sunitinib (as maleate) 25 mg capsule

15-B00-096 EDL2

15-B00-066 Sunitinib maleate 12.5 mg capsule EDL2

15-B00-067 Sunitinib maleate 50 mg capsule EDL1
15-B00-068 Sorafenib (as tosylsate) 200 mg tablet EDL1
15-B00-069 Dasatinib as monohydrate 100 mg tab EDL2
15-B00-070 Nilotinib as Hcl monohydrate 200 mg cap. EDL1
15-B00-080 Nilotinib as Hcl monohydrate 150 mg cap EDL1
15-B00-089 Ruxolitinib 5 mg tablet EDL3
15-B00-090 Ruxolitinib 15 mg tablet EDL1
15-B00-094 pazopanib Hcl 200mg film coated tab EDL1
Imatinib as mesylate (Protein - Tyrosine kinase
15-B00-075
inhibitor) 400mg capsule

Imatinib as mesylate (Protein - Tyrosine kinase

15-B00-050
inhibitor) 400mg Tablet
EDL1
 Imatinib as mesylate (Protein- Tyrosine kinase
15-B00-028
inhibitor) 50mg Capsule

Imatinib as mesylate (Protein - Tyrosine kinase

15-B00-029
inhibitor) 100mg Capsule
EDL1

Imatinib as mesylate (Protein - Tyrosine kinase

15-B00-030
inhibitor) 50mg Tablet

Imatinib as mesylate (Protein - Tyrosine kinase

15-B00-031
inhibitor) 100mg Tablet

15-B00-056 Erlotinib as Hcl 25mg Tablet

15-B00-057 Erlotinib as Hcl 100mg Tablet

15-B00-058 Erlotinib as Hcl 150mg Tablet EDL2

palbociclib, 125mg tab
00-000-000 EDL1

Abemaciclib 150mg, film coated tablet

00-000-000 EDL1

Cytomegalovirus immunoglobulin(solution of human

cytomegalovirus immunoglobulin for i.v
administration 1ml contains : human normal
immunoglobulin solution for infusion 10% + human
plasma protein , 100mg/ml there of immunoglobulin
15-B00-021 EDL3
95%) 50 ml vial

15-B00-005 Corynebacterium parvum 7mg Injection

Normal immunoglobulin human 50mg per 1

ml,100mg/ml
Purity of at least 97% IgG( IgG1 66.6%, IgG2 27.9%,
IgG3%, IgG42.5%)
5% (10ml=0.5g,50ml=2.5g,100ml=5g,200ml=10g,
15-B00-109
400ml=20g)

15C DRUGS USED IN NEUTROPENIA

15-C00-001 Molgramostim (GM-CSF) Recombinant Human
granulocyte macrophage -colony stimulating factor
150mcg vial

15-C00-002 Molgramostim (GM-CSF) Recombinant Human

granulocyte macrophage -colony stimulating factor
300mcg vial

15-C00-003 Filgrastim 300mcg(30MU) /1ml S.C/I.V infusion inj

(solution) Vial or Filgrastim 300mcg(30MU) /0.5 ml
EDL1
pfs

00-000-00 Accofil : 30 MU PFS( Filgrastim 30MU solution for

injection in 0.5ml(0.6mg\ml)IV or S.C PFS)
BIOSIMILAR Biosimilar

15-C00-010 Nivestim pfs: filgrastim 300 mcg(30MU)/1ml

Biosimilar

00-000-00 Zarzio : Filgrastim 30 (MU)/ /0.5 ml , 48 (MU)//0.5

ml solution for inj. ( for i.v or s.c )
Biosimilar

15-C00-004 Filgrastim 480mcg(48MU) /1.6mlS.C/I.V infusion

(solution) Vial

15-C00-005 Oprelvekin inj. 5mg vial (Platelete growth Factor for

thrombocytopenia)

15-C00-007 Filgrastim 480mcg(48MU) /0.5ml S.C / I.V infusion

(solution)prefilled syring

15-C00-008 Pegfilgrastim ( expressed as filgrastim) s.c inj :-

6mg/0.6 ml PFS.

00-000-00 Pelgraz 6mg pfs( pegFilgrastim 6mg solution for

injection in 0.6ml(10mg\ml) S.C PFS) BIOSIMLAR
Biosimilar

15-C00-009 Lenograstim powder for reconstitution , 33.6 million

IU ( 263 µg) vial (with 1 ml prefilled syringe water for
EDL1
injections)

15D TAXANE GROUP

15-D00-001 Docetaxel 40mg/ml (0.5ml vial) EDL3
15-D00-002 Docetaxel (Anhydrous or as Trihydrate
)10mg/1ml ,8ml vial OR
20mg/1ml ,4ml vial EDL1
OR 80mg/2ml Vial (all with diluent)

15-D00-005 Docetaxel 10mg/1ml, 2ml or Docetaxel 20mg/ml, 1

ml vial or pfs
EDL1

00-000-00 docetaxel 10 mg/ml, 16 ml vial

15-D00-003 Paclitaxel 6mg/ml 5ml vial

15-D00-004 Paclitaxel 6mg/ml 50ml vial EDL1

15E CYTOSTATIC TOPOISOMERASE (1) INHIBITOR
15-E00-001 Irinotecan Hcl or Hcl Trihydrate 20mg/ml 2ml I.V.
Infusion Vial

15-E00-002 Irinotecan Hcl or Hcl Trihydrate 20mg/ml 5ml I.V.

Infusion Vial
EDL1

15F others
15-F00-001 8
2-8x10 CFU TICE BCG
(for bladder cancer/bladder carcinoma)
EDL1

15-F00-002 8 9
2x10 – 3x10 (RIVM ) BCG (for bladder
cancer/bladder carcinoma)
EDL1
‫‪SUPPRESSION‬‬
‫عنوان‬
‫عنوان‬
‫غيرمسجل‬
‫غيرمسجل‬
‫غيرمسجل‬
‫مسجل‬
‫غيرمسجل‬
‫مسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬
‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬
‫غيرمسجل‬
‫مسجل‬
‫غيرمسجل‬
‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬
‫مسجل‬
 ‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫عنوان‬

‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬
‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬
 ‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل ‪ 50‬ملغم ‪ 5/‬مل‬

‫مسجل‬

‫مسجل‬

‫عنوان‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬
 ‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬
‫عنوان‬
‫غيرمسجل‬
‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬
 ‫مسجل‬
‫عنوان‬

‫غير مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬
‫مسجل‬
‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
 ‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬
‫مسجل‬
‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬ ‫ج\‪1088‬‬

‫ج\‪1088‬‬
‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬
‫مسجل‬
‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غير مسجل‬

‫ج\‪1087‬‬
‫مسجل‬
‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬
 ‫مسجل‬

‫عنوان‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬
‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬
‫مسجل‬
‫مسجل‬
 ‫مسجل‬
‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫عنوان‬

‫مسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
 ‫مسجل‬

‫مسجل‬

‫مسجل‬
‫غيرمسجل‬
‫غيرمسجل‬
‫غيرمسجل‬
‫مسجل‬
‫مسجل‬
‫مسجل‬
‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬
‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬
‫مسجل‬
‫مسجل‬
‫مسجل‬
‫غيرمسجل‬
‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬
‫مسجل‬

‫غيرمسجل‬
 ‫مسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬
‫مسجل‬
‫مسجل‬
‫مسجل‬
‫غيرمسجل‬
‫مسجل‬
‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬
‫مسجل‬
‫مسجل‬
‫غيرمسجل‬
‫مسجل‬
‫مسجل‬
‫مسجل‬
‫مسجل‬
‫غيرمسجل‬

‫مسجل‬

‫مسجل‬
‫غيرمسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬
‫مسجل‬
‫مسجل‬
‫ج\‪1087‬‬
‫مسجل‬
‫ج\‪1087‬‬
‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫عنوان‬
‫غيرمسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬

‫غيرمسجل‬

‫عنوان‬
‫غيرمسجل‬

‫مسجل‬

‫مسجل‬

‫غيرمسجل‬
‫مسجل‬
‫مسجل‬
‫عنوان‬

‫مسجل‬

‫مسجل‬

‫عنوان‬

‫غيرمسجل‬

‫غيرمسجل‬